Company intelligence / Profile preview

ichorbio

Wantage, Oxfordshire, United Kingdomichor.bio ↗

Ownership: Private
Development stage: Commercial

Overview

ichorbio does not conduct clinical trials or develop therapeutics; instead it manufactures high-quality monoclonal antibodies and biosimilars used by researchers worldwide to advance drug discovery and disease understanding. The company is recognized for its focus on oncology research tools and commitment to supporting scientific progress through reliable reagents at competitive prices.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Monoclonal antibodyBiosimilarAntibody-drug conjugate (for research use)
Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships disclosed; company collaborates with academic researchers and other biotech firms primarily as a reagent supplier

Beyond the preview

Go deeper on ichorbio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ichorbio.

Explore the full profile